6-K/A - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

EFFECT - NewGenIvf Group Ltd (0001981662) (Filer)

F-1/A - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

F-1 - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

BANGKOK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it is implementing a reverse stock split of all of the Company's issued and unissued shares, including the Class A ordinary shares with no par value (the "Class A Ordinary Shares"), Class B ordinary shares with no par value and preferred shares with no par value, at an exchange ratio of one (1) share for twenty (20) shares (the "Reverse Stock Split"). The Reverse Stock Split was approved by the Company's Board of Directors on January 21, 20

The technology, which will be acquired for US$5 million, allows for the separation of X and Y chromosome-bearing sperm cells MicroSort offers several advantages for those seeking reproductive assistance and prevention of certain genetic disorders BANGKOK, Thailand, Jan. 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has entered into a definitive agreement to acquire MicroSort, a proprietary sperm-sorting technology that enhances the Company's capabilities in providing assisted reproductive s

BANGKOK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the launch of its innovative lifetime egg freezing service in Asia. The innovative "one charge, no worries" fertility preservation solution is designed to serve the growing needs of women across Asia, and will allow customers to make a one-time payment to arrange for lifetime egg freezing. NewGen's new service addresses a robust market opportunity, particularly in light of increasing demand for egg freezing services in the region. The global eg

BANGKOK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that both parties involved in the previously announced reverse merger with European Wellness Investment Holdings Limited ("EWIHL") have appointed legal counsel to prepare the Share Purchase Agreement (the "SPA"). Additionally, by mutual consent, the signing date for the SPA has been extended from January 27, 2025, to February 28, 2025. This extension will allow both parties sufficient time to complete the necessary due diligence, finalize the terms of the agreement, and ensure compliance with all relevant NASDAQ requirements for reverse mergers. This significant ste

NewGen has deployed US$1 million to execute the purchase of its carefully planned digital asset portfolio The company aims to take advantage of positive trends in the crypto landscape by executing a well-crafted strategic investment plan BANGKOK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that it has engaged OSL Digital Securities ("OSL"), a leading regulated digital asset platform in Hong Kong, as part of NewGen's intent to begin investing in the digital assets space. Following the engagement, NewGen has transferred funds in the amount of US$1 million to its account. These funds will serve as a pilot tranche to ca

US$452 million transaction at deemed price of US$3.20 per NewGen share Increased market capitalization and visibility will support NewGen's continued listing on the Nasdaq Global Market Proposed transaction holds significant potential for synergistic value creation BANGKOK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that it has entered into a binding term sheet (the "Term Sheet") regarding the previously announced proposed reverse merger with healthcare company European Wellness Investment Holdings Limited ("EWIHL"). Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, "We are ple

BANGKOK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that on November 21 2024, it received written notice (the "Delisting Notice") from The Nasdaq Stock Market LLC ("Nasdaq") that its securities are subject to delisting due to non-compliance with two Nasdaq Listing Rules. The Company has filed to appeal the delisting determination and plans to leverage several strategic actions to regain compliance with Nasdaq's listing requirements. NewGen had previously received two letters from Nasdaq in regard to its non-compliance with Nasdaq's Listing Rules in May 2024. The first letter (the "MVPHS Deficiency Letter") notified t

BANGKOK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), today announced that it has entered into a binding term sheet (the "Term Sheet") with White Lion Capital, LLC, ("White Lion") a California-based institutional investor focused on high-growth, early-stage public companies, setting out the principal terms and conditions for a $100 million equity line of credit, expandable to $500 million. Pursuant to the Term Sheet, NewGen will have the option, but not the obligation, to sell to White Lion up to $100.0 million in shares of common stock over an initial 36-month period, with the potential to increase to $300.0 million upon substantial

BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), today announced that on October 8, 2024, the Company received a letter (the "Deficiency Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is currently not in compliance with the closing bid price requirement under Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule"). The Deficiency Letter notified the Company that, for the preceding 30 consecutive business days, the Company's Class A Ordinary Shares (the "Class A Shares") did not meet the minimum closing bid price of $1 per share pursuant to

Total Revenues Reach US$5.1 MillionGross Profit Increases by 9.4% to US$1.7 MillionNet Income of US$0.1 million BANGKOK, Thailand, Aug. 21, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that on August 19, 2024, the Company filed its 2023 annual report (20-F) with the SEC. 2023 Financial Highlights Total revenues were US$5.1 million in the full year of 2023.Gross profit increased by 9.4% to US$1.7 million from US$1.5 million in the full year of 2022.Gross margin was 32.8%, compared to 25.9% in the full year of 202

SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)